Formulation and Evaluation of Etoposide-loaded Dextran polymeric nanoparticles fabricated with Hyaluronic acid for the treatment of colorectal cancer using network pharmacology, in-silico, in-vitro, and in-vivo approaches.
Haluronic acid-functionalized dextran (HA)-functionalized dextran (DEX) polymeric nanoparticles offer a promising, targeted nanoplatform that addresses ETP's limitations, boosting therapeutic efficacy and safety for CRC treatment.